Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
2
×
abbvie
alkermes
allergan
america
biotech
boston blog main
boston top stories
buprenorphine
cariprazine
chronic pain
clinical trials
eli lilly
europe blog main
europe top stories
fda
felipe jain
health
jess fiedorowicz
jessica jeffrey
karim calis
khosla ventures
life sciences
lumateperone
m health fairview
marc goodman
massachusetts general hospital
medicine
national blog main
national institutes of health (nih)
national top stories
new york
olanzapine
opioid
ottawa hospital
pain
physical therapy
samidorphan
san francisco
steven meisel
What
prescribed
2
×
ago
alkermes
antipsychotic
based
benefits
billion
caveats
commonly
company
costs
designed
disorders
drug
effect
europe
favor
fda
financing
founded
gain
health
healthcare
khosla
market
medicine
million
muscular
new
offer
panel
physical
psyche
raised
raises
roughly
round
skeletal
slash
spends
Language
unset
Current search:
prescribed
×
europe
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@techcrunch.com
5 years ago
Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures